Overview

Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Recurrent ICD shocks are a serious problem in pts with ICD. Treatment failure with other antiarrhythmics and ablation are common. Dronedarone is a new antiarrhythmic drug with ion channel properties similar to amiodarone. Several case reports have shown promising results with Dronedarone for this patient population.
Phase:
N/A
Details
Lead Sponsor:
Rabin Medical Center
Treatments:
Amiodarone
Dronedarone